Transfusion and Haematology Today - Issue 3/2013

Comprehensive Reports, Original Papers, Case Reports

125

Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II

A. Jonášová, J. Čermák, L. Červinek, L. Nováková, P. Bělohlávková, J. Vondráková, O. Černá, M. Sýkora, N. Seifertová, L. Walterová, J. Libiger, I. Hochová, J. Ullrychová, P. Rohoň, J. Obernauerová, M. Schutzova, V. Vozobulová, H. Poláčková, K. Kačmářová, J. Mužík

134

The importance of serum immunoglobulin free light chain assay in AL amyloidosis

T. Pika, P. Lochman, J. Minařík, J. Bačovský, V. Ščudla

140

Lymphomas of gastrointestinal tract – clinico-pathological review

A. Janíková, I. Zambo, A. Baumeisterová, M. Hermanová, J. Mayer

152

Plasma cell leukaemia

T. Jelínek, H. Plonková, R. Hájek

163

Current treatment of myelofibrosis based on risk stratification of patients

M. Palová, K. Indrák, A. Hluší, T. Szotkowski